Abstract
Objective To study the efficacy of rosiglitazone combined with metformin on patients with non -alcoholic fatty liver diseases (NAFLD).Methods One hundred and twenty patients with non -alcoholic fatty liver disease were randomly divided into three groups:control group,rosiglitazone treatment group,and rosiglitazone combined with metformin treatment group,6 months were one cycle in all three groups.The evaluating indexes including body mass index( BMI),blood lipid,liver enzyme activities,fasting blood glucose ( FPG),fasting blood insulin ( FBI),insulin resistance index ( IRI),clinical symptoms,physical signs,and results of B - ultrasonic examination in liver.Results The patients treated with rosiglitazone or combined with metformin,levels of TC,TG,ALT,AST and IRI were obviously improved than those before treatment( P < 0.05 ).The patients treated with rosightazone combined with metformin,levels of BMI were obviously improved than those before treatment( P <0.05).The total effective rates in these groups were significantly higher than that in control group( P <0.01 ).Conclusions The treatment of pioglitazone is safe and effective to NAFLD,and the therapeutic effect of combination use is superior to that of pioglitazone or metformin use alone. Key words: Rosiglitazone; Metformin; Non - alcoholic fatty live disease
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.